Search
for
Sort by
Research 781–810 of 1000+
- 7. Surgery and Laser
- Minoxidil.
- Hair Follicle Transglutaminases and the Formation of ε-(γ-Glutamyl) Cross-links
- Phosphodiesterase inhibitors used in androgenic alopecia as a possible risk factor for testicular tumor
- How to Deal with the Issues of Fertility, Malignancies, and the Postfinasteride Syndrome while Prescribing Finasteride for Male Pattern Hair Loss
- Coloration in Equine: Overview of Candidate Genes Associated with Coat Color Phenotypes
- Microbioreactor design for eukaryotic cell-based biomedical applications
- Comparative Analysis of Clinical Outcomes in Patients With Type 2 Diabetes Mellitus on Monotherapy Versus Combination Therapy
- Integrative Whole-Transcriptome Sequencing Analysis of Skin Tissues with Different Coat Types in Cashmere Goats Across Stages of Hair Follicle Development
- Understanding Modern Hair Restoration: Long-Term Planning and Scalp Health
- Understanding Modern Hair Restoration: Long-Term Planning and Scalp Health
- Contraindications of Using Fractional CO<sub>2</sub> Laser in the Treatment of Aesthetic Disorders: A Narrative Review
- Medical workup for hair loss
- Current Treatments for Alopecia Areata
- Human epithelial stem cell survival within their niche requires “tonic” cannabinoid receptor 1‐signalling—Lessons from the hair follicle
- 33766 Efficacy of baricitinib in patients with various degrees of alopecia areata severity: Results from BRAVE-AA1 and BRAVE-AA2
- Dutasteride
- IPL sources and ruby lasers for hair reduction - trying to compare apples and oranges
- Editors' Picks
- Inhibition of 5α-Reductase Activity in SZ95 Sebocytes and HaCaT Keratinocytes <i>In Vitro</i>
- FDA Approved pediatric antihypertensive agents
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Successful treatment of alopecia universalis with abrocitinib: a case report
- 33774 Baricitinib results in eyebrow and eyelash growth in patients with alopecia areata who do not achieve 20% or less scalp hair loss
- ADVERSE EFFECTS OF RITLECITINIB IN ADULTS AND ADOLESCENTS WITH ALOPECIA AREATA: A LITERATURE REVIEW
- Review of Promising Off-Label Use of Deucravacitinib
- 556 α 1 -AR agonist induced piloerection protects against the development of traction alopecia
- P62 Pre-clinical pharmacological and skin penetration profile of LDE255, a novel and specific Smoothened antagonist
- Laser hair removal
- Emollients: application of topical treatments to the skin